Cadila Healthcare spurts as USFDA approves its Moraiya facilities

17 Jul 2012 Evaluate

Cadila Healthcare is currently trading at Rs. 835.20, up by 36.45 points or 4.56% from its previous closing of Rs. 798.75 on the BSE.

The scrip opened at Rs. 810.00 and has touched a high and low of Rs. 843.00 and Rs. 805.00 respectively. So far 28823 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 983.50 on 19-Jul-2011 and a 52 week low of Rs. 629.00 on 25-Jan-2012.

Last one week high and low of the scrip stood at Rs. 802.35 and Rs. 759.05 respectively. The current market cap of the company is Rs. 17101.62 crore.

The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 16.51% and 8.70% respectively.

Cadila Healthcare has received a letter from US Food and Drug Administration (USFDA), conveying that the facilities at Moraiya are acceptable. The USFDA had earlier issued a warning letter to the company but with this it is been resolved.

Cadila Healthcare focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

The company has posted a rise of 55.30% in its net profit at Rs 139.40 crore for the quarter ended March 31, 2012 as compared to Rs 89.76 crore for the same quarter in the previous year. Total income has increased by 13.95% at Rs 795.86 crore for quarter under review as compared Rs 698.41 crore for the quarter ended March 31, 2011.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×